Tower Research Capital LLC (TRC) - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 160 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$13,000
-7.1%
3,285
-14.7%
0.00%
Q4 2021$14,000
-88.5%
3,851
-88.6%
0.00%
-100.0%
Q3 2021$122,000
+388.0%
33,695
+488.8%
0.00%
+200.0%
Q2 2021$25,000
-67.5%
5,723
-69.4%
0.00%0.0%
Q1 2021$77,000
-21.4%
18,705
-24.2%
0.00%
-66.7%
Q4 2020$98,000
-80.6%
24,680
-86.8%
0.00%
-50.0%
Q3 2020$505,000
+420.6%
186,811
+431.6%
0.01%
+50.0%
Q2 2020$97,00035,139
+35039.0%
0.00%
Q4 2019$0
-100.0%
100
-91.7%
0.00%
Q3 2019$4,000
-20.0%
1,209
-29.1%
0.00%
Q4 2018$5,000
-88.4%
1,706
-86.7%
0.00%
-100.0%
Q3 2018$43,000
+2050.0%
12,804
+1438.9%
0.00%
Q1 2018$2,000
-77.8%
832
-81.2%
0.00%
-100.0%
Q4 2017$9,000
-84.7%
4,416
-75.5%
0.00%
-80.0%
Q3 2017$59,000
-1.7%
17,994
-15.8%
0.01%
-16.7%
Q1 2017$60,000
+17.6%
21,373
-3.3%
0.01%0.0%
Q4 2016$51,000
+50.0%
22,094
+7.9%
0.01%
+100.0%
Q3 2016$34,000
+277.8%
20,474
+145.9%
0.00%
+200.0%
Q2 2016$9,0008,327
+4329.3%
0.00%
Q1 2016$0
-100.0%
188
-99.2%
0.00%
-100.0%
Q4 2015$29,000
+190.0%
24,314
+326.0%
0.01%
+400.0%
Q3 2015$10,000
-50.0%
5,707
-38.7%
0.00%
-50.0%
Q2 2015$20,000
-13.0%
9,312
+9.5%
0.00%
-33.3%
Q1 2015$23,000
+2200.0%
8,502
+4108.9%
0.00%
Q4 2014$1,000
-98.8%
202
-99.6%
0.00%
-100.0%
Q3 2014$84,000
+44.8%
46,028
+222.0%
0.01%
+50.0%
Q3 2013$58,00014,2930.01%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders